Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorogenic acid injection versus lomustine for recurrent grade IV glioblastoma
CTR20181644Phase 2Active
- Sponsor
- Sichuan Jiuzhang Biotechnology
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorogenic acid in glioblastoma (GBM), sponsored by Sichuan Jiuzhang Biotechnology. Started Feb 2019; status: active.
02
Drugs
chlorogenic acid
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on CTR20181644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181644.